| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Haemophilus influenzae (ESBL) |
0.015 |
0.03 |
0.008 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox)  |
195 |
| Haemophilus influenzae (ESBL) |
0.015 |
0.03 |
≤0.015 － 0.03 |
Cefixime (Suprax) |
267 |
| Haemophilus influenzae (ESBL) |
0.015 |
0.03 |
0.015 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox) |
130 |
| Haemophilus influenzae (ESBL) |
0.015 |
0.03 |
0.015 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox) |
443 |
| Haemophilus influenzae (ESBL) |
0.016 |
0.016 |
0.008 － 0.125 |
Levofloxacin (Levaquin, Quixin) |
85 |
| Haemophilus influenzae (ESBL) |
≤0.016 |
≤0.016 |
≤0.016 － <=0.016 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
19 |
| Haemophilus influenzae (ESBL) |
0.016 |
0.031 |
≤0.016 － 0.031 |
Levofloxacin (Levaquin, Quixin) |
19 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － 0.06 |
Ofloxacin (Floxin) |
114 |
| Haemophilus influenzae (ESBL) |
<0.03 |
<0.03 |
<0.03 － 0.06 |
Ofloxacin (Floxin) |
84 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － 0.06 |
Ofloxacin (Floxin) |
195 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － 0.12 |
Cefepime (Maxipime) |
114 |
| Haemophilus influenzae (ESBL) |
<0.03 |
<0.03 |
<0.03 － 0.12 |
Cefixime (Suprax) |
84 |
| Haemophilus influenzae (ESBL) |
<0.03 |
<0.03 |
<0.03 － 0.12 |
Cefpodoxime |
84 |
| Haemophilus influenzae (ESBL) |
<0.03 |
<0.03 |
<0.03 － 1 |
Cefixime (Suprax) |
84 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － 1 |
Levofloxacin (Levaquin, Quixin) |
499 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
499 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － ? |
Levofloxacin (Levaquin, Quixin) |
195 |
| Haemophilus influenzae (ESBL) |
≤0.03 |
≤0.03 |
≤0.03 － ? |
Trovafloxacin (Trovan) |
195 |
| Haemophilus influenzae (ESBL) |
0.03 |
0.06 |
≤0.004 － 4 |
Cefixime (Suprax) |
119 |
| Haemophilus influenzae (ESBL) |
0.03 |
0.06 |
? － ? |
Moxalactam (Latamoxef) |
1389 |
| Haemophilus influenzae (ESBL) |
0.03 |
0.12 |
<0.03 － 0.5 |
Cefpodoxime |
84 |
| Haemophilus influenzae (ESBL) |
0.03 |
0.12 |
≤0.03 － 0.5 |
Cefpodoxime |
114 |
| Haemophilus influenzae (ESBL) |
0.03 |
0.12 |
≤0.03 － 0.5 |
Cefpodoxime |
195 |
| Haemophilus influenzae (ESBL) |
0.031 |
0.031 |
≤0.016 － 0.063 |
Ofloxacin (Floxin) |
19 |
| Haemophilus influenzae (ESBL) |
0.031 |
0.063 |
≤0.016 － 0.125 |
Moxifloxacin (BAY 12-8039, Avelox) |
19 |
| Haemophilus influenzae (ESBL) |
≤0.05 |
≤0.05 |
? － ? |
Ampicillin (Omnipen) |
36 |
| Haemophilus influenzae (ESBL) |
0.06 |
0.06 |
≤0.03 － 0.12 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
186 |
| Haemophilus influenzae (ESBL) |
0.06 |
0.06 |
≤0.03 － 0.12 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
186 |